David A Scheinberg - Net Worth and Insider Trading

David A Scheinberg Net Worth

The estimated net worth of David A Scheinberg is at least $189,359 dollars as of 2025-07-25. David A Scheinberg is the Director of Progenics Pharmaceuticals Inc and owns about 46,185 shares of Progenics Pharmaceuticals Inc (PGNX) stock worth over $189,359. David A Scheinberg is also the Director of ContraFect Corp and owns about 20 shares of ContraFect Corp (CFRXQ) stock worth over $0. Details can be seen in David A Scheinberg's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David A Scheinberg has not made any transactions after 2014-07-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of David A Scheinberg

To

David A Scheinberg Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David A Scheinberg owns 3 companies in total, including SELLAS Life Sciences Group Inc (SLS) , Progenics Pharmaceuticals Inc (PGNX) , and ContraFect Corp (CFRXQ) .

Click here to see the complete history of David A Scheinberg’s form 4 insider trades.

Insider Ownership Summary of David A Scheinberg

Ticker Company Transaction Date Type of Owner
SLS SELLAS Life Sciences Group Inc 2019-03-14 director
PGNX Progenics Pharmaceuticals Inc 2019-07-11 director
CFRXQ ContraFect Corp 2014-07-28 director

David A Scheinberg Latest Holdings Summary

David A Scheinberg currently owns a total of 2 stocks. Among these stocks, David A Scheinberg owns 46,185 shares of Progenics Pharmaceuticals Inc (PGNX) as of February 23, 2012, with a value of $189,359 and a weighting of 100%. David A Scheinberg also owns 20 shares of ContraFect Corp (CFRXQ) as of July 28, 2014, with a value of $0 and a weighting of 0%.

Latest Holdings of David A Scheinberg

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PGNX Progenics Pharmaceuticals Inc 2012-02-23 46,185 4.10 189,359
CFRXQ ContraFect Corp 2014-07-28 20 0.00 0

Holding Weightings of David A Scheinberg


David A Scheinberg Form 4 Trading Tracker

According to the SEC Form 4 filings, David A Scheinberg has made a total of 0 transactions in Progenics Pharmaceuticals Inc (PGNX) over the past 5 years. The most-recent trade in Progenics Pharmaceuticals Inc is the sale of 1,250 shares on February 23, 2012, which brought David A Scheinberg around $12,500.

According to the SEC Form 4 filings, David A Scheinberg has made a total of 0 transactions in ContraFect Corp (CFRXQ) over the past 5 years. The most-recent trade in ContraFect Corp is the sale of 0 shares on July 28, 2014, which brought David A Scheinberg around $0.

Insider Trading History of David A Scheinberg

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David A Scheinberg Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

David A Scheinberg Ownership Network

Ownership Network List of David A Scheinberg

No Data

Ownership Network Relation of David A Scheinberg

Insider Network Chart


David A Scheinberg Owned Company Details

What does SELLAS Life Sciences Group Inc do?

Who are the key executives at SELLAS Life Sciences Group Inc?

David A Scheinberg is the director of SELLAS Life Sciences Group Inc. Other key executives at SELLAS Life Sciences Group Inc include EVP & Gen. Counsel & Corp. Sec. Barbara A Wood , VP & Finance & Corp Controller John Thomas Burns , and director & President and CEO Angelos M. Stergiou .

SELLAS Life Sciences Group Inc (SLS) Insider Trades Summary

Over the past 18 months, David A Scheinberg made no insider transaction in SELLAS Life Sciences Group Inc (SLS). Other recent insider transactions involving SELLAS Life Sciences Group Inc (SLS) include a net purchase of 20,000 shares made by Jane Wasman , a net purchase of 20,000 shares made by Katherine Bach Kalin , and a net purchase of 10,000 shares made by Van Nostrand Robert L .

In summary, during the past 3 months, insiders sold 0 shares of SELLAS Life Sciences Group Inc (SLS) in total and bought 50,000 shares, with a net purchase of 50,000 shares. During the past 18 months, 0 shares of SELLAS Life Sciences Group Inc (SLS) were sold and 50,000 shares were bought by its insiders, resulting in a net purchase of 50,000 shares.

SELLAS Life Sciences Group Inc (SLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

SELLAS Life Sciences Group Inc Insider Transactions

No Available Data

David A Scheinberg Mailing Address

Above is the net worth, insider trading, and ownership report for David A Scheinberg. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, David A Scheinberg's mailing address is: New York Ny 10025.